Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Liver Disease and Transplantation, and Hepatitis B Virus Studies.
Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990–2021
Differences in Phage Recognition and Immunogenicity Contribute to Divergent Human Immune Responses to <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Phages
Enhancement of Inpatient Mortality Prognostication With Machine Learning in a Prospective Global Cohort of Patients With Cirrhosis With External Validation
Assessment of metabolic dysfunction‐associated fatty liver disease in primary care: a consensus statement summary
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease
Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis
Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature
Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease
Telomere length and mortality in lean MAFLD: the other face of metabolic adaptation
Accurate non-invasive detection of MASH with fibrosis F2-F3 using a lightweight machine learning model with minimal clinical and metabolomic variables
The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases
Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis
Serum PRO‐C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort
Lipoprotein (a) in the Full Spectrum of Metabolic Dysfunction-associated Steatotic Liver Disease: Evidence From Histologically and Genetically Characterized Cohorts
The Freiburg Index of Post‐<scp>TIPS</scp> Survival accurately predicts mortality in patients with acute decompensation of cirrhosis
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia
Breaking new ground: MASLD vs. MAFLD—which holds the key for risk stratification?
Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study
MAFLD: an optimal framework for understanding liver cancer phenotypes
Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogramming
Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study